Healthcare

PepsiCo’s $5.2 million donation to look at lifestyle and chronic disease looks like an act of the archest cynicism. But someone needs to do something, says Nuala Moran.

Two of Europe’s gene therapy pioneers have reported significant progress in the last week, bringing commercial gene therapy products yet closer to reality.

Nanotechnology is beginning to leave the laboratory and hit the high street – but health scares could stop this commercialisation process in its tracks.